Compare Stocks

→ Wall Street Legend Issues New NVDA Warning (From Chaikin Analytics) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARMP Armata Pharmaceuticals	$2.59 +3.6%	$0.00	$1.07 ▼ $5.26	$93.63M	0.85	17,048 shs	3,170 shs
BGT BlackRock Floating Rate Income Trust	$12.87 -0.9%	$12.97	$10.95 ▼ $13.42	N/A	N/A	101,255 shs	53,462 shs
FAB First Trust Multi Cap Value AlphaDEX Fund	$78.76 -1.1%	$79.30	$64.89 ▼ $82.62	$153.58M	1.22	5,462 shs	1,883 shs

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARMP Armata Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%
BGT BlackRock Floating Rate Income Trust	+0.08%	+2.20%	+1.41%	+6.13%	+14.96%
FAB First Trust Multi Cap Value AlphaDEX Fund	-0.01%	+3.04%	-1.04%	+3.70%	+17.94%

Mysterious Gold Leverage Just Announced (Ad)

World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.

Find out what it is and see how you can get in with just a few dollars.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARMP Armata Pharmaceuticals	2.4339 of 5 stars	3.5	5.0	0.0	0.0	0.6	1.7	0.6
BGT BlackRock Floating Rate Income Trust	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARMP Armata Pharmaceuticals	3.00	Buy	$7.00	170.27% Upside
BGT BlackRock Floating Rate Income Trust	N/A	N/A	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	0.00	N/A	$86.80	10.20% Upside

Current Analyst Ratings

Latest ARMP, IMM, SCLP, FAB, and BGT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/22/2024	ARMP Armata Pharmaceuticals	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$7.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARMP Armata Pharmaceuticals	$4.53M	20.67	N/A	N/A	($0.89) per share	-2.91
BGT BlackRock Floating Rate Income Trust	$39.39M	N/A	N/A	N/A	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARMP Armata Pharmaceuticals	-$69.04M	-$1.98	N/A	N/A	N/A	-1,524.51%	-280.95%	-52.61%	5/9/2024 (Estimated)
BGT BlackRock Floating Rate Income Trust	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	11.74	∞	N/A	N/A	N/A	N/A	N/A

Latest ARMP, IMM, SCLP, FAB, and BGT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/21/2024	Q4 2023	ARMP Armata Pharmaceuticals	N/A	-$0.55	-$0.55	-$0.55	$0.68 million	$1.53 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARMP Armata Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
BGT BlackRock Floating Rate Income Trust	$1.39	10.80%	+12.82%	N/A	2 Years
FAB First Trust Multi Cap Value AlphaDEX Fund	$1.48	1.88%	N/A	N/A	N/A

Latest ARMP, IMM, SCLP, FAB, and BGT Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/1/2024	BGT BlackRock Floating Rate Income Trust	Monthly	$0.12	10.98%	4/12/2024	4/15/2024	4/30/2024
3/1/2024	BGT BlackRock Floating Rate Income Trust	Monthly	$0.12	11.07%	3/14/2024	3/15/2024	3/28/2024
3/20/2024	FAB First Trust Multi Cap Value AlphaDEX Fund	Quarterly	$0.2430		3/21/2024	3/22/2024	3/28/2024
2/1/2024	BGT BlackRock Floating Rate Income Trust	Monthly	$0.12	11.65%	2/14/2024	2/15/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARMP Armata Pharmaceuticals	N/A	1.16	1.16
BGT BlackRock Floating Rate Income Trust	N/A	N/A	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ARMP Armata Pharmaceuticals	3.57%
BGT BlackRock Floating Rate Income Trust	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A

Insider Ownership

Company	Insider Ownership
ARMP Armata Pharmaceuticals	85.50%
BGT BlackRock Floating Rate Income Trust	N/A
FAB First Trust Multi Cap Value AlphaDEX Fund	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ARMP Armata Pharmaceuticals	66	36.15 million	5.24 million	Not Optionable
BGT BlackRock Floating Rate Income Trust	N/A	N/A	N/A	Not Optionable
FAB First Trust Multi Cap Value AlphaDEX Fund	147,000	1.95 million	N/A	Not Optionable

ARMP, IMM, SCLP, FAB, and BGT Headlines

Source	Headline
	First Trust Multi Cap Value AlphaDEX Fund (NASDAQ:FAB) Short Interest Up 200.0% in March marketbeat.com - April 10 at 4:43 PM
	First Trust Mid Cap Core AlphaDEX® Fund declares $0.4394 dividend msn.com - December 22 at 1:05 PM
	First Trust Multi Cap Growth AlphaDEX Fund wsj.com - May 18 at 10:40 PM
	FAB First Trust Multi Cap Value AlphaDEX® Fund ETF seekingalpha.com - April 28 at 8:40 AM
	First Trust Exchange-Traded AlphaDEX Fund - First Trust Large Cap Growth AlphaDEX Fund (NASDAQ: FTC) fool.com - January 7 at 1:29 PM
	First Trust Brazil AlphaDEX Fund declares quarterly distribution of $0.1018 msn.com - December 23 at 1:31 PM
	First Trust Multi Cap Value AlphaDEX Fund declares quarterly distribution of $0.4778 msn.com - December 23 at 1:31 PM
	Analysts See 28% Upside For The Holdings of FAB nasdaq.com - September 23 at 7:25 AM
	Is First Trust Multi Cap Value AlphaDEX ETF (FAB) a Strong ETF Right Now? finance.yahoo.com - August 22 at 8:36 AM
	Surprising Analyst 12-Month Target For FAB nasdaq.com - July 24 at 6:04 PM
	Third Avenue Small-Cap Value Fund Q1 2022 Portfolio Manager Commentary seekingalpha.com - May 25 at 1:27 AM
	First Trust Multi Cap Value AlphaDEX Fund declares quarterly distribution of $0.2096 seekingalpha.com - March 25 at 5:05 PM
	Analysts Predict 16% Gains Ahead For The Holdings of FAB nasdaq.com - March 4 at 8:18 AM
	Implied FAB Analyst Target Price: $86 nasdaq.com - February 10 at 9:52 AM
	First Trust Multi Cap Value AlphaDEX Fund (FAB) nasdaq.com - January 22 at 7:59 PM
	Implied FAB Analyst Target Price: $84 nasdaq.com - January 12 at 10:54 AM
	Peek Under The Hood: FAB Has 11% Upside nasdaq.com - January 4 at 2:27 PM
	How The Parts Add Up: FAB Headed For $83 nasdaq.com - November 15 at 12:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Foot Locker Builds Up Another Head of Steam; Gains Imminent
March 28, 2024 10:58 AM
View Foot Locker Builds Up Another Head of Steam; Gains Imminent
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 9, 2024 6:07 AM
View Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Silicon Motion Proves That AI in Motion Stays in Motion
April 16, 2024 11:42 AM
View Silicon Motion Proves That AI in Motion Stays in Motion
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024 6:05 AM
View Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
High-Yielding Verizon’s Stock Price Reversal is Imminent
April 22, 2024 8:45 AM
View High-Yielding Verizon’s Stock Price Reversal is Imminent

All Headlines

Company Descriptions

Armata Pharmaceuticals

NYSEAMERICAN:ARMP

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California.

BlackRock Floating Rate Income Trust

NYSE:BGT

BlackRock Floating Rate Income Trust is a close ended fixed income mutual fund launched by BlackRoack Inc. The fund is co-managed by BlackRock Advisors, LLC and BlackRock Financial Management, Inc. It invests in the fixed income markets across the globe while focusing on the United States. The fund invests in bonds of companies operating across diversified sectors. It invests in corporate bonds with average effective duration of its portfolio will be no more than 1.5 years. The fund was formerly known as BlackRock Global Floating Rate Income Trust. BlackRock Floating Rate Income Trust was formed on August 30, 2004 and is domiciled in the United States.

First Trust Multi Cap Value AlphaDEX Fund

NASDAQ:FAB

The First Trust Multi Cap Value AlphaDEX Fund (FAB) is an exchange-traded fund that is based on the NASDAQ AlphaDEX Multi Cap Value index. The fund tracks an index that uses fundamental factors to select and weight value stocks from the Nasdaq US Select Indices. FAB was launched on May 8, 2007 and is managed by First Trust.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial